CAD-31? A novel Alzheimer’s disease drug c...
Infinite1 10 Jan 2018
Ran across this article and figured it would be of interest to this group, figured I would share.
Full text: A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism
CAD-31 appears to be an analog of J147 which was initially derived from Curcumin. It looks very promising from looking over this article, not certain about how it would pan out in application-- might be difficult acquiring such a compound.
tunt01 10 Jan 2018
A new study on J147, profiled as an ATP synthase inhibitor and modulator of CAMKK2, which is probably a common pathway shared by resveratrol.
By targeting ATP synthase, J147 causes an increase in intracellular calcium leading to sustained calcium/calmodulin-dependent protein kinase kinase β (CAMKK2)-dependent activation of the AMPK/mTOR pathway, a canonical longevity mechanism
Goldberg, J., Currais, A., Prior, M., Fischer, W., Chiruta, C., & Ratliff, E. et al. (2018). The mitochondrial ATP synthase is a shared drug target for aging and dementia. Aging Cell, e12715. doi:10.1111/acel.12715
recon 08 Mar 2018
I found this while doing deeper searches on J147. Bump in case someone knows how can we procure this.
This seems to be a more potent analog of J147.
This seems to be a more potent analog of J147.